LinkedIn video ad examples

What if nutrition moved to the center of kidney care? At our satellite symposium at the International Congress on Renal Nutrition and Metabolism (ICRNM) in Berlin, experts explored how nutrition can play a more central role in treatment and patient support. Watch the video to hear Prof. Denis Fouque on why nutrition belongs at the heart of kidney care and renal dietitian Carla Avesani, PhD, on how nutritional recommendations can translate into meaningful patient support. Across the Fresenius Group, we are shaping the future of medical nutrition and kidney care. #FreseniusCommittedToLife #FutureFresenius #ChronicKidneyDisease

LBA has been the gold standard for biologics PK for decades, but it measures one analyte at a time. Learn how hybrid LBA-LC-MS enables multiplex analysis for multidomain therapeutics, providing multiple readouts from a single sample.

𝗘𝘃𝗲𝗿𝘆𝗼𝗻𝗲’𝘀 𝘁𝗮𝗹𝗸𝗶𝗻𝗴 𝗮𝗯𝗼𝘂𝘁 𝗽𝗿𝗼𝘁𝗲𝗶𝗻. But most of the conversation starts with muscle. And stops there. The truth is, protein does a lot more than most of us give it credit for. It plays a role in 𝗲𝘃𝗲𝗿𝘆𝗱𝗮𝘆 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗿𝗲𝗰𝗼𝘃𝗲𝗿𝘆, and it helps support how the body builds and maintains itself over time. Join Kelly Dingess, to discover the power of protein beyond the obvious. 🎬 Tap play below for a first look. You'll find the 𝗳𝘂𝗹𝗹 𝘃𝗶𝗱𝗲𝗼 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀. 👇 Special thanks to Ardy van Helvoort, Andrew Holwerda, Muriel Alkemade-Bots, and Rianne Halsberghe.

With free payload circulating at pg/mL concentrations against an ADC dosed in the µg/mL range, even minimal linker cleavage can impact PK results. Learn how LC-MS supports free payload analysis through assay design, linker stability controls, and light-sensitivity testing.

L’edizione di quest’anno del Barometro della resilienza sanitaria classifica la resilienza dei sistemi sanitari di 42 Paesi attraverso quattro aree chiave: sicurezza del paziente, forza lavoro, sostenibilità ambientale ed efficienza. In ogni nuova edizione, il Barometro supporta leader e decisori del settore a rafforzare le performance dei sistemi in contesti di crescente pressione, aiutandoli a confrontare i propri risultati, individuare vulnerabilità poco evidenti e definire con maggiore consapevolezza le priorità di intervento. Scarica il report completo per approfondire i risultati.

Préparer les systèmes de santé aux défis de demain Pressions sur les ressources, évolution de la demande, nouveaux risques : le Baromètre BD identifie les leviers clés pour renforcer durablement la résilience des systèmes de santé.

Support can mean meeting people where they are as they navigate their relationship with opioids, with care that adapts to their needs over time.

For HCPs in the UK and Ireland only. This post has been developed in collaboration with, and funded by, Boehringer Ingelheim. References available via the linked resource below. We wouldn't do a cardiovascular disease review without a blood pressure reading. So why do we do them without a uACR? Sometimes we come across data so stark that it makes you stop and think – how can we do better in our clinical practice? 66% of adults with recorded hypertension in England did not receive a uACR test in the last 12 months preceding December 2025 [Data extracted from CVDPrevent; accessed at: https://lnkd.in/di3xrbEy]. CKD isn't just a kidney problem, it is a cardiovascular problem! People with CKD are 6x more likely to experience a major cardiovascular event and are more likely to die from a heart attack or stroke than ever reaching end-stage renal disease (Based on Greater Manchester data) [Boehringer Ingelheim. Data on file. CRM 2-131025]. Albuminuria, measured by a urine ACR test, is an independent cardiovascular risk marker. Even modest rises can be associated with dramatically higher CV risk, including a 69% increased risk of CV disease [Xia et al, Int J Clin Exp Med 2015]. And it can signal damage to the structure of the kidneys way before eGFR has moved at all. The uACR test is simple. It's cheap and it requires little more than the right bottle to collect it in. When interpreted alongside clinical assessment, eGFR and other established cardiovascular risk factors, uACR identifies people with or at risk of kidney damage earlier, enables better risk stratification, and informs timely use of evidence-based therapies that can slow progression and reduce CV risk in accordance with current clinical guidance. Yet, despite all our guidelines recommending testing, the majority of patients with hypertension are being missed, meaning we can’t know for sure just how high their cardiovascular risk is… We can do better. uACR should be part of every cardiovascular review. 👇 Watch the video and click on the link below for more. And if this resonates, share it. Let's get the word out there and let’s get testing. https://lnkd.in/dc-pFrWg NP-GB-107940 v2 | October 2026

On 23 December, the Farmak brand marks 100 years. A milestone built over decades, shaped by experience and carried forward through everyday work. Today is a moment to pause and recognise the people behind the work — past and present. 📍 More on the 100-year story: https://lnkd.in/grmppbYu

From dossier to production — one integrated system. At Farmak International, sterile injectables are managed as a continuous process: from development through to commercial supply. 🔬 Dossier development is handled internally, enabling faster adaptation to local requirements and reducing external dependencies. ⚙️ Development, scale-up, and manufacturing are aligned within one workflow, supporting smoother transitions to commercial production. 📦 Dedicated injectables capacity across formats allows more structured and predictable supply planning. 🔄 Processes are designed and maintained within the same system, ensuring consistency across batches and lifecycle stages. For partners, this means clearer ownership and more predictable timelines from registration to launch with fewer variables along the way. ▶️ See how this system works in practice: https://lnkd.in/devFp7JK

At Baupharma, the greatest strength is the people. In this interview, Chief Digital Officer, Michaela Rehorovska, shares her journey with Baupharma and her perspective on what makes our multinational, multicultural team so unique. From diverse backgrounds and experiences to a shared commitment to collaboration and excellence, Baupharma’s people are at the heart of everything done. 𝗪𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝗶𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄 𝘁𝗼 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗵𝗼𝘄 𝗮 𝗴𝗹𝗼𝗯𝗮𝗹 𝘁𝗲𝗮𝗺 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘁𝗼 𝗱𝗿𝗶𝘃𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗼𝘂𝗻𝗱 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 👇 #Baupharma #Leadership #TeamCulture #LifeAtBaupharma #Pharmacovigilance #LifeSciences #Healthcare

What could a connected ZEISS system make easier? Unlock digital services and apps that can accelerate support, reduce coordination and keep eligible systems up to date. Discover the benefits of connectivity: https://zeiss.ly/con-v-b 👈

What could a connected ZEISS system make easier? Unlock digital services and apps that can accelerate support, reduce coordination and keep eligible systems up to date. Discover the benefits of connectivity: https://zeiss.ly/con-V-A 👈

#CancerDuSein | Prendre soin, c’est aussi regarder au-delà de la maladie 🎗️ Face au cancer, la qualité de la prise en charge se joue aussi dans le quotidien des patients. Préserver l’image et l’estime de soi, accompagner les répercussions sur la vie personnelle, autant de dimensions qui comptent dans le parcours de soin. Mieux prendre en compte ces dimensions, favoriser le dialogue et permettre aux patients d'exprimer leurs besoins sont autant d'éléments qui contribuent à un accompagnement plus global et plus personnalisé. Chez Bayer, notre ambition est de contribuer à améliorer la qualité de vie des patients, à chaque étape de leur parcours, en soutenant une approche qui intègre la qualité de vie aux côtés des enjeux de santé. 🎥 Dans cette vidéo, Abdelali (Ali) MAJDI, Directeur Médical de Bayer | Pharmaceuticals France, partage la conviction de Bayer en faveur d’une prise en charge qui va au-delà de la maladie et place la qualité de vie au cœur du parcours des patients. Alors que le mois de sensibilisation au cancer du sein touche à sa fin, novembre ouvre un nouveau temps fort autour de la santé masculine, notamment du cancer de la prostate. 🩷➡️💙 Bayer poursuit son engagement en oncologie pour contribuer à améliorer la vie des patients à chaque étape de leur parcours. Delphine PAGANO, Thibaut Leturgez, Abdelali (Ali) MAJDI, Alexandra Dekeyser, Chloé Martel, Laura Cordero , Guillemette Grenet (Barre), Anne-Sophie Mackowiak #BayerFrance #TeamBayer #Oncologie #CancerDuSein #CancerProstate

Światowy Dzień Donacji i Transplantacji to okazja, by zwrócić uwagę na znaczenie transplantacji w ratowaniu zdrowia i życia oraz zatrzymać się na chwilę przy temacie dawstwa narządów🫁. W Chiesi troska o zdrowie i życie ludzi jest wpisana w nasze DNA. Dlatego chcemy wykorzystywać takie dni również do budowania świadomości i zachęcania do refleksji nad decyzjami, które mogą mieć znaczenie dla innych ❤️.

#BayerRecrute | De nouvelles opportunités vous attendent à Boissay ! 🌱 Vous souhaitez mettre vos compétences au service de projets agricoles innovants ? Sur notre site de Boissay, les opportunités sont variées : métiers de terrain, agronomie, nouvelles technologies agricoles... autant de façons de contribuer à la recherche et au développement dans le domaine des semences. 📍 À Boissay, Toury (Eure-et-Loir), rejoignez un centre de Recherche & Développement dédié notamment aux semences de colza, de maïs et de blé hybride, à seulement 1h de Paris. 🌾

At Almirall, we think in generations. For more than 80 years, our journey has been guided by scientific rigour, an entrepreneurial mindset and a clear purpose: to help improve the lives of people living with skin conditions. 🧬 From our first laboratory in Barcelona to our presence in more than 100 countries today, we have stayed true to who we are: a family-owned company with a long-term vision and a strong commitment to medical dermatology. We believe innovation matters most when it responds to real patient needs and brings science closer to care. 👉🏻Discover the milestones that have shaped our journey. #WeAreAlmirall #MedicalDermatology #OurHistory

Two powders, poured the same way. One flows. One doesn’t. What’s the difference? This is one of my favorite demonstrations to share, because it proves that a smooth production run often starts at the formulation stage. The powder on the right uses our Advanced Powder Technology. We combine beadlet and granulation technologies, pre-formulated into the premix, with the right mineral product forms, so it’s easier to handle, dose, and process. The powder on the left shows why that’s important. Low or inconsistent flow can disrupt production and, in severe cases, block equipment completely. In the final product, it can mean lumps and uneven dosages. In my experience, flowability is easy to underestimate until it starts costing time on the line. This is exactly the kind of challenge we will be discussing during our webinar on November 16. We’ll talk through the six technology platforms behind Advanced Powder Technology, share real case studies, and look at what it all means for your business. If you work in formulation or production, I’d highly recommend tuning in: 🎤 Beyond Premix: Unlocking performance with Advanced Powder Technology 📅 November 16 | 16:00 CET 🔗 Register here: https://bit.ly/4zCQG9m #AdvancedPowderTechnology #Formulation #PremixSolutions

Für den Einsatz in unterschiedlichen Arbeitsumgebungen ausgelegt: Das robuste X-am 8600 misst toxische und brennbare Gase, Dämpfe sowie Sauerstoff gleichzeitig.

Das kontrastreiche Farbdisplay zeigt Messwerte gut lesbar an. Bei einem Alarm warnt das X-am 8600 optisch, akustisch und durch Vibration – damit wichtige Hinweise im Einsatz wahrnehmbar sind.

🔎 Estão abertas as candidaturas à Bolsa de Investigação Científica B. Braun Augusta Pinheiro, promovida pela APECE Associação Portuguesa de Enfermeiros de Cuidados em Estomaterapia, em parceria com a B. Braun. Renata Teixeira, Head of Marketing & Sales da B. Braun, destaca a importância desta iniciativa, que nasce com o objetivo de incentivar e apoiar a investigação em Enfermagem de Estomaterapia em Portugal, contribuindo para o desenvolvimento do conhecimento, para a melhoria dos cuidados e para a qualidade de vida das pessoas com ostomia. ➡️ Consulte o regulamento e condições

Weren’t you in Barcelona? Good news: we brought it all back. The first TriMemo and Memo 4D Curve experiences. Seven years of MANTRA data on Perceval Plus. Crimson in action. "With Nitinol-based technology, you raise the bar." Dr Marco Di Eusanio It’s all waiting for you here: https://lnkd.in/eNjB_k73 #EACTS2026 #Corcym #SurgeonOfTheFuture

A complex clinical case remained unexplained for an extended period following a surgical complication. With the support of Amplifier AI technology, the issue was identified in just two minutes. In this account, Vinicius H. Nasr, Commercial Director for Brazil and Latin America at Amplifier AI, shares how technology can help bridge the gaps between medical imaging, the identification of abnormalities, and procedure planning, supporting faster, better-informed clinical decisions. Amplifier AI is working to transform medical images into structured information, supporting physicians and clinical teams in procedure preparation. #AmplifierAI #MedicalImaging #HealthcareInnovation #AIinHealthcare

We’re catching up with #TeamBeOne in the moment to hear what’s emerging from #ESMO26 this year. Hear their takes on the science catching attention and what it could mean for the field – and for patients. Discover how we're changing the game in solid tumor oncology: https://bit.ly/4z5cT0g #BeOneAgainstCancer #FromFloorToFeed